Skip to main content
رجوع
Watch Compare

ProMIS Neurosciences Inc.

جودة البيانات: 83%
PMN
Nasdaq Manufacturing Chemicals
KWD 12.07
▲ KWD 1.37 (12.80%)
القيمة السوقية: 108.24 M
السعر
KWD 12.07
القيمة السوقية
108.24 M
نطاق اليوم
KWD 11.25 — KWD 12.77
نطاق 52 أسبوعًا
KWD 6.27 — KWD 39.75
حجم التداول
44,317
فتح KWD 11.25
متوسط 50 يوم / 200 يوم
KWD 16.65
27.50% below
متوسط 50 يوم / 200 يوم
KWD 12.77
5.49% below

Quick Summary

النقاط الرئيسية

Earnings declined -1529.33% over the past year
Negative free cash flow of -28.12 M

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)-1529.33%
FCF Growth (3Y)N/A

الجودة

Return on Equity
-902.22%
أقل من متوسط القطاع (-53.47%)
ROIC-710.49%
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
N/A
Current Ratio1.76
Interest CoverageN/A

التقييم

PE (TTM)
-2.73
أقل من متوسط القطاع (-1.47)
P/B Ratio11.78
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (1364 نظير)
المقياس السهم وسيط القطاع
P/E -2.7 -1.5
P/B 11.8 1.6
ROE % -902.2 -53.5
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

ETFs Holding This Stock

TBGVX TBGVX
0.77% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) -1529.33% Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -39.72 M
ROE -902.22% ROA -256.52%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -28.12 M
ROIC -710.49% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 1.76
Interest Coverage N/A Asset Turnover N/A
Working Capital 9.25 M Tangible Book Value 9.19 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -2.73 Forward P/E N/A
P/B Ratio 11.78 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -25.98%
Market Cap 108.24 M Enterprise Value 92.84 M
Per Share
EPS (Diluted TTM) -22.61 Revenue / Share N/A
FCF / Share -3.14 OCF / Share -3.14
EPS CAGR (1Y) -20654.55% EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 70.79%
SBC-Adj. FCF -28.89 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Revenue — — — —
Net Income -39.72 M 2.78 M -13.21 M -18.06 M
EPS (Diluted) -22.61 0.11 -1.07 -2.41
Gross Profit — — — —
Operating Income -40.17 M -16.83 M -14.26 M -23.38 M
EBITDA — — — —
R&D Expenses 33.38 M 10.64 M 7.88 M 16.09 M
SG&A Expenses — — — —
D&A — — — —
Interest Expense — — 282,064.0 282,064.0
Income Tax — 0.0 0.0 —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Total Assets 9.18 M 18.91 M 13.62 M 6.92 M
Total Liabilities 10.44 M 2.42 M 9.87 M 8.27 M
Shareholders' Equity -1.26 M 16.49 M 3.75 M -1.35 M
Total Debt — — 0.0 3.91 M
Cash & Equivalents 6.12 M 13.29 M 12.60 M 5.88 M
Current Assets 9.18 M 18.91 M 13.62 M 6.90 M
Current Liabilities 10.41 M 2.22 M 9.35 M 6.41 M